It was reported recently that a distinct family of auto-antibodies which recognise carbamylated antigens, the anti-carbamylated protein antibodies, are predictive of a severe disease course in early RA patients even after correction for RF and ACPA. The gene discussed is PRTN3; the disease is rheumatoid arthritis.